Theratechnologies (THTX) presented data from a real-world, observational, registry study demonstrating the efficacy and safety of ibalizumab in ...

Results show similar levels of virus undetectability in patients on ibalizumab-containing regimens as in controls, despite greater baseline ...

The trial is designed to assess risk factors and predictors of virologic and immunologic response in HTE people with HIV (PWH) and specific sub-populations. Its primary objective is to evaluate ...

The following is a summary of “Telemedicine virologic and immunologic outcomes in people living with HIV (PLWH) in a ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

Results show similar levels of virus undetectability in patients on ibalizumab-containing regimens as in controls, despite greater baseline severity of HIV Ibalizumab continues to demonstrate long ...

“The availability of long-term injectable therapies has not eliminated the phenomenon of multidrug resistance, and heavily treatment-experienced people with HIV deserve fully suppressive ...

"The availability of long-term injectable therapies has not eliminated the phenomenon of multidrug resistance, and heavily treatment-experienced people with HIV deserve fully suppressive ...

THIS is a report of virologic and serologic studies of a family experience with paralytic poliomyelitis that involved all 3 members, father, mother and daughter, and of serologic studies of an ...